ConductScience.org, home

Paper36969241

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.

Bonilla H and 24 others. Front Immunol, 2023. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Papers, record 36969241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969241

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.
PubMed
Journal
Front Immunol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
9.23
iCite
Revised in PubMed
2026-09-03
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonilla HHector
2Peluso MJMichael J
3Rodgers KKathleen
4Aberg JAJudith A
5Patterson TFThomas F
6Tamburro RRobert
7Baizer LLawrence
8Goldman JDJason D
9Rouphael NNadine
10Deitchman AAmelia
11Fine JJeffrey
12Fontelo PPaul
13Kim AYArthur Y
14Shaw GGwendolyn
15Stratford JJeran
16Ceger PPatricia
17Costantine MMMaged M
18Fisher LLiza
19O'Brien LLisa
20Maughan CChristine

Source PubMed

See all 25 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Virus DiseasesMajor topic
United States
Humans
SARS-CoV-2
Post-Acute COVID-19 Syndrome
Motivation

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K23 AI157875NIAID NIH HHSUnited StatesK23AI157875PubMed and NIHNIH RePORTER
L30 AI147159NIAID NIH HHSUnited StatesL30AI147159PubMed and NIHNIH RePORTER
OT2 HL161847NHLBI NIH HHSUnited StatesOT2HL161847PubMed and NIHNIH RePORTER
UM1 TR004528NCATS NIH HHSUnited StatesUM1TR004528PubMedNIH RePORTER

Download CSV of grants

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120632887Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature.J Infect Dis2010https://conductscience.org/library/papers/20632887PubMed
232953984CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease.Mol Ther Oncolytics2020https://conductscience.org/library/papers/32953984PubMed
333631065Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/33631065PubMed
432678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
535215212Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms.Pathogens2022https://conductscience.org/library/papers/35215212PubMed
634921756Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.Lancet2022https://conductscience.org/library/papers/34921756PubMed
734677601Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.J Infect Dis2021https://conductscience.org/library/papers/34677601PubMed
836113467Epstein-Barr virus: Biology and clinical disease.Cell2022https://conductscience.org/library/papers/36113467PubMed
935709281Clues to long COVID.Science2022https://conductscience.org/library/papers/35709281PubMed
1036337437High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial.Lancet Reg Health Eur2023https://conductscience.org/library/papers/36337437PubMed
1126965674HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.Nat Rev Neurol2016https://conductscience.org/library/papers/26965674PubMed
1235226158Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT.Eur Radiol2022https://conductscience.org/library/papers/35226158PubMed
1328603794Post-Exertional Malaise in Patients with ME and CFS with Comorbid Fibromyalgia.SRL Neurol Neurosurg2017https://conductscience.org/library/papers/28603794PubMed
1436517603SARS-CoV-2 infection and persistence in the human body and brain at autopsy.Nature2022https://conductscience.org/library/papers/36517603PubMed
1534445329Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders.Int J Mol Sci2021https://conductscience.org/library/papers/34445329PubMed
1634425843Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.Cardiovasc Diabetol2021https://conductscience.org/library/papers/34425843PubMed
1735240997Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19.BMC Infect Dis2022https://conductscience.org/library/papers/35240997PubMed
1833536023
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole.
J Transl Med2021https://conductscience.org/library/papers/33536023PubMed
1935082169Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.Gut2022https://conductscience.org/library/papers/35082169PubMed
2035768006Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.Cell2022https://conductscience.org/library/papers/35768006PubMed

See all 123 referencesDownload CSV of references

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
42964321Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany: the PreVitaCOV randomised clinical trial.EClinicalMedicine2026https://conductscience.org/library/papers/42964321PubMed
42521821Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial.Nat Med2026https://conductscience.org/library/papers/42521821PubMed
42313767Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative.PLoS One2026https://conductscience.org/library/papers/42313767PubMed
42163969The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments.EClinicalMedicine2026https://conductscience.org/library/papers/42163969PubMed
42075130Multi-Strain Probiotic Intervention Modestly Modulates Microbial Composition and Inflammatory Profile in Individuals with Long COVID.Microorganisms2026https://conductscience.org/library/papers/42075130PubMed
42056279Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID.Commun Med (Lond)2026https://conductscience.org/library/papers/42056279PubMed
41993482Intranasal Anti-CD3 Antibody Treatment Attenuates Post-COVID Neuroinflammation and Enhances Hippocampal Neurogenesis and Cognitive Function in Mice.bioRxiv2026https://conductscience.org/library/papers/41993482PubMed
41975034Understanding the long-term neurological effects of SARS-CoV-2 infection.Nat Rev Neurol2026https://conductscience.org/library/papers/41975034PubMed
41969525Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and in silico therapeutic targeting.Front Cell Neurosci2026https://conductscience.org/library/papers/41969525PubMed
41917225Long COVID disability burden in US adults.Commun Med (Lond)2026https://conductscience.org/library/papers/41917225PubMed
41875425Differential Factors Associated With the Presence of Persistent Symptoms in Individuals Diagnosed With Long COVID: Protocol for a Longitudinal Matched Case-Control Study.JMIR Res Protoc2026https://conductscience.org/library/papers/41875425PubMed
41642863Children and adolescents: Respiratory infection and long-term effects longitudinal study (CARE Study): Study protocol.PLoS One2026https://conductscience.org/library/papers/41642863PubMed
41598473Impact of Pulmonary Rehabilitation on Physical, Mental Health and Quality of Life in Children with Post-COVID-19 Condition: A 12-Month Quasi-Experimental Study.J Clin Med2026https://conductscience.org/library/papers/41598473PubMed
41438970Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study.EClinicalMedicine2025https://conductscience.org/library/papers/41438970PubMed
41387017Patient perspectives on the usability and content validity of the assessment of burden of chronic conditions tool for post-COVID in the Netherlands: a qualitative study.BMJ Open2025https://conductscience.org/library/papers/41387017PubMed
41330562Persistent sleep symptoms in post-COVID syndrome: a Brazilian prospective clinical study.Arq Neuropsiquiatr2025https://conductscience.org/library/papers/41330562PubMed
41318861Lingering echoes of SARS-CoV-2: mechanistic insights and management of long COVID syndrome.Inflammopharmacology2026https://conductscience.org/library/papers/41318861PubMed
41235241Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair.Front Immunol2025https://conductscience.org/library/papers/41235241PubMed
41158347The post-COVID-19 pulmonary sequelae: manifestations, mechanisms and treatment strategies.J Thorac Dis2025https://conductscience.org/library/papers/41158347PubMed
41157147The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome.Molecules2025https://conductscience.org/library/papers/41157147PubMed

See all 58 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36969241

GET https://conductscience.org/api/papers/v1/36969241/authors?page=2